Antiplatelet medications: Difference between revisions
No edit summary |
(add References section, add See Also section) |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
==List== | ==List== | ||
*Irreversible [[COX inhibitor|cyclooxygenase inhibitors]] | *Irreversible [[COX inhibitor|cyclooxygenase inhibitors]] | ||
** [[Aspirin]] | **[[Aspirin]] | ||
** [[Triflusal]] (Disgren) | **[[Triflusal]] (Disgren) | ||
*[[Adenosine diphosphate (ADP) receptor inhibitor]]s | *[[Adenosine diphosphate (ADP) receptor inhibitor]]s | ||
**[[Clopidogrel]] (Plavix) | **[[Clopidogrel]] (Plavix) | ||
| Line 23: | Line 23: | ||
***[[Terutroban]] | ***[[Terutroban]] | ||
[[Category: | |||
==See Also== | |||
*[[Antiplatelet agent reversal]] | |||
*[[Acute coronary syndrome]] | |||
*[[Stroke]] | |||
==References== | |||
<references/> | |||
[[Category:Pharmacology]] | |||
Latest revision as of 08:46, 22 March 2026
List
- Irreversible cyclooxygenase inhibitors
- Adenosine diphosphate (ADP) receptor inhibitors
- Clopidogrel (Plavix)
- Prasugrel (Effient)
- Ticagrelor (Brilinta)
- Ticlopidine (Ticlid)
- Phosphodiesterase inhibitors
- Cilostazol (Pletal)
- Protease-activated receptor-1 (PAR-1) antagonists
- Vorapaxar (Zontivity)
- Glycoprotein IIB/IIIA inhibitors (intravenous use only)
- Abciximab (ReoPro)
- Eptifibatide (Integrilin)
- Tirofiban (Aggrastat)
- Adenosine reuptake inhibitors
- Dipyridamole (Persantine)
- Thromboxane inhibitors